1. Home
  2. VSTA vs MDWD Comparison

VSTA vs MDWD Comparison

Compare VSTA & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vasta Platform Limited

VSTA

Vasta Platform Limited

HOLD

Current Price

$4.90

Market Cap

401.2M

Sector

Real Estate

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

N/A

Current Price

$18.78

Market Cap

238.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VSTA
MDWD
Founded
1966
2000
Country
Brazil
Israel
Employees
N/A
111
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
401.2M
238.5M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
VSTA
MDWD
Price
$4.90
$18.78
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$37.50
AVG Volume (30 Days)
9.8K
97.7K
Earning Date
11-06-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
$326,007,430.00
$20,932,000.00
Revenue This Year
$11.22
$15.89
Revenue Next Year
$13.43
$25.33
P/E Ratio
$4.21
N/A
Revenue Growth
13.60
6.15
52 Week Low
$1.60
$14.14
52 Week High
$5.49
$22.51

Technical Indicators

Market Signals
Indicator
VSTA
MDWD
Relative Strength Index (RSI) 45.21 55.40
Support Level $4.90 $18.55
Resistance Level $4.99 $19.40
Average True Range (ATR) 0.09 0.61
MACD -0.01 0.08
Stochastic Oscillator 77.77 66.40

Price Performance

Historical Comparison
VSTA
MDWD

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: